SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release first quarter 2018 financial results after the market close on Wednesday, May 9, 2018. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PDT (4:30 p.m. EDT) on May 9,
Author: Business Wire
Global Dry Eye Epidemiology and Patient Flow Analysis 2017-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Dry Eye epidemiology, Dry Eye diagnosed patients, and Dry Eye tr…
Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. The research provides insights into Diabetic Macular Edema epidemiology, Diabetic Mac…
Age-Related Macular Degeneration Pipeline Highlights Report 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Age-Related Macular Degeneration Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products in the global Age-Relat…
Zenni Optical Marks 15th Anniversary by Selling 20 Millionth Pair of Glasses
NOVATO, Calif.–(BUSINESS WIRE)–#15yearsofZenni–Zenni Optical, the online optical industry leader, celebrates 15 years of innovation this month with a milestone of 20 million pairs of glasses sold.
Additional Clinical Studies Supporting the Benefits of OMIDRIA® Presented at the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER) announced that the results of four real-world clinical studies evaluating the benefits of OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1% / 0.3% were presented at the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting held in Washington, D.C., April 13-17, 2018. The studies examined the use of OMIDRIA in both routine and complex cataract surgery cases perf
$13 Billion Contact Lenses Market – Global Outlook and Forecast 2018-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lenses Market – Global Outlook and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering. The global contact lenses market is anticipated to generate revenues of more than $13 billion by 20…
2018 Macular Edema Pipeline Highlights – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Macular Edema Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. Macular Edema Pipeline Highlights – 2018 provides the most up-to-date information on key pipeline products in the global…
Ophthalmology Pipeline Database 2018: Conjunctivitis, Glaucoma, Diabetic Retinopathy, Myasthenia Gravis, Dry Eye Syndrome, Age-related Macular Degeneration, and Cataract – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Pipeline Database – 2018” report has been added to ResearchAndMarkets.com’s offering. Ophthalmology Pipeline Highlights Database – 2018, provides most up-to-date information on key pipeline products in the gl…
Global Dry Eye Pipeline Highlights 2018-2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Pipeline Highlights – 2018” report has been added to ResearchAndMarkets.com’s offering. Dry Eye Pipeline Highlights – 2018 provides most up-to-date information on key pipeline products in the global Dry eye market….
Global Vision Care Market – Innovative Product Launches to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)–#Health–Technavio’s latest market research report on the global vision care market provides an analysis of the most important trends and drivers.
Zenni Optical Announces Flexible Frames Line – Expanding Its Comprehensive Eyeglass Offering for Kids and Toddlers
NOVATO, Calif.–(BUSINESS WIRE)–Zenni Optical launches a new Kids’ Flexible Glasses Collection, featuring eight unique frame styles and a virtually unbreakable design.
Data from BioTime’s OpRegen® and Retinal Restoration Programs to Be Presented at ARVO 2018
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that data from the ongoing OpRegen® clinical trial and Retinal Restoration program will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) meeting taking place from April 29th – May 3rd, 2018, in Honolulu, Hawaii. The scheduled times (noted in local Hawaii time) and location of the BioTime data presen
SERI Lugano: la FDA selecciona la riboflavina ParaCel para su uso como parte del protocolo de reticulación sin extirpación del epitelio para el tratamiento del queratocono
LUGANO, Suiza–(BUSINESS WIRE)–El Switzerland Eye Research Institute ha anunciado que la innovadora formulación de la riboflavina transepitelial, conocida como ParaCel, basada en la investigación de su CEO y fundador, Roberto Pinelli, MD, ha sido seleccionada entre muchas otras formulaciones por la FDA (Administración de Alimentos y Fármacos de EE. UU.) para un protocolo de reticulación (cross-linking, CXL) de colágeno corneal sin extirpación del epitelio (epi-on) en pacientes que padecen quer
SERI Lugano: la FDA selecciona la riboflavina ParaCel para su uso como parte del protocolo de reticulación sin extirpación del epitelio para el tratamiento del queratocono
LUGANO, Suiza–(BUSINESS WIRE)–El Switzerland Eye Research Institute ha anunciado que la innovadora formulación de la riboflavina transepitelial, conocida como ParaCel, basada en la investigación de su CEO y fundador, Roberto Pinelli, MD, ha sido seleccionada entre muchas otras formulaciones por la FDA (Administración de Alimentos y Fármacos de EE. UU.) para un protocolo de reticulación (cross-linking, CXL) de colágeno corneal sin extirpación del epitelio (epi-on) en pacientes que padecen quer
IDE Pivotal Trial Results for Glaukos’ iStent inject® Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery
SAN CLEMENTE, Calif. & WASHINGTON–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that two-year U.S. Investigational Device Exemption (IDE) pivotal trial data showed that its iStent inject® Trabecular Micro-Bypass System achieved a statistically significant reduction in unmedicated diurnal intraocul
Eye Care Leaders Showcases Entire 2015-Certified Portfolio at ASCRS/ASOA 2018
CHARLOTTE, N.C.–(BUSINESS WIRE)–#2015cehrt–Eye Care Leaders will present their comprehensive portfolio of HITRUST and 2015 certified solutions at booth #1942 at the ASCRS•ASOA Annual Symposium.
Glaukos Files Patent Infringement Lawsuit Against Ivantis, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that it has filed a patent infringement lawsuit against Ivantis, Inc. in the U.S. District Court for the Central District of California, Southern Division. The lawsuit alleges that Ivantis’ Hydrus Microstent device infringes Glauko
Global Diabetic Eye Disease Devices Market – Latest Developments by Technavio
LONDON–(BUSINESS WIRE)–#MedicalDevices–Market research firm Technavio has announced the release of their latest report on the global diabetic eye disease devices market for 2018-2022.
Global Cataract Surgical Devices Market 2018-2023 – IOLs are the Most Popular Product Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering. According to the report, the global cataract su…